Journals / Turkish Journal of Pharmaceutical Sciences / 2022 / Cilt: 19 - Sayı: 1

Novel Indole Derivative as the First P-glycoprotein Inhibitor from the Skin of Indian Toad (Bufo melanostictus)

P-glikoprotein İnhibitörü Olarak Hint Kurbağası (Bufo melanostictus) Derisinden İlk Kez Elde Edilen Yeni Bir İndol Türevi

Pages
63–69
Publication Date
2022-11-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: The NID has shown increased clear permeability P app (x10-6 cm/sec) significantly (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: To study the inhibitory effect of novel indole derivative (NID) from Indian toad skin (Bufo melanostictus) on permeability glycoprotein (P-gp).
📊
Key Findings & Data:Materials and Methods: Dried Indian toad skin was used to isolate NID with column chromatography, and its structure was elucidated by infrared spectra, 13 C nuclear magnetic resonance (NMR), 1 H NMR spectra, and liquid chromatography-mass spectrometry.
💡
Conclusion & Impact:Results: The NID has shown increased clear permeability P app (x10-6 cm/sec) significantly (p
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: To study the inhibitory effect of novel indole derivative (NID) from Indian toad skin (Bufo melanostictus) on permeability glycoprotein (P-gp). Materials and Methods: Dried Indian toad skin was used to isolate NID with column chromatography, and its structure was elucidated by infrared spectra, 13 C nuclear magnetic resonance (NMR), 1 H NMR spectra, and liquid chromatography-mass spectrometry. Female Wistar rats were used to determine LD 50, in vitro permeability studies were done with the intestinal sac method, and in vivo pharmacokinetic studies were carried out to prove the P-gp inhibition using the rat model. Results: The NID has shown increased clear permeability P app (x10-6 cm/sec) significantly (p

Özet

Amaç: Hint kurbağa derisinden (Bufo melanostictus) elde edilen yeni indol türevinin (NID) permeabilite glikoproteini (P-gp) üzerindeki inhibitör etkisini incelemek. Gereç ve Yöntemler: NID, kurutulmuş Hint kurbağası derisinden kolon kromatografisi ile elde edilmiş ve yapı tayini infrared spektoskopisi, 13 C nükleer magnetic rezonans (NMR), 1 H NMR spektroskopisi ve sıvı kromatografisi-kütle spektrometrisi ile gerçekleştirilmiştir. LD50 , dişi Witsar sıçanlar kullanılarak belirlenmiştir, in vitro permeabilite çalışmaları intestinal kese yöntemi ile, ve P-gp inhibisyonunu doğrulamak amacıyla in vivo farmakokinetik çalışmalar, rat modeli kullanılarak gerçekleştirilmiştir. Bulgular: NID’nin, ileumda 1,04±0,11’den 2,90±0,08’e; jejunumda 1,44±0,14’ten 3,92±0,13’e önemli ölçüde (p

🔖

Cite This Article

NEERATI, P., MUNIGADAPA, S. (2022). Novel Indole Derivative as the First P-glycoprotein Inhibitor from the Skin of Indian Toad (Bufo melanostictus). Turkish Journal of Pharmaceutical Sciences, Cilt: 19 - Sayı: 1, 63–69. https://ajindex.com/articles/613599

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. . Zhang Y. Why do we study animal toxins? Dongwuxue Yanjiu. 2015;36:183-222. 2. Utkin YN. Animal venom studies: Current benefits and future developments. World J Biol Chem. 2015;6:28-33. 3. Peigneur S, Tytgat J. Toxins in drug discovery and pharmacology. Toxins (Basel). 2018;10:126. 4. Qi J, Tan CK, Hashimi SM, Zulfiker AH, Good D, Wei MQ. Toad glandular secretions and skin extractions as anti-inflammatory and anticancer agents. Evid Based Complement Alternat Med. 2014;2014:312684. 5. Urban MC, Phillips BL, Skelly DK, Shine R. A toad more traveled: the heterogeneous invasion dynamics of cane toads in Australia. Am Nat. 2008;171:E134-E148. 6. Garg A, Hippargi R, Gandhare A. Toad skin-secretions: potent source of pharmacologically and therapeutically significant compounds. Int J Pharmacol. 2007;5:17. 7. Mills JW, Prum BE. Morphology of the exocrine glands of the frog skin. Am J Anat. 1984;171:91-106. 8. Jared C, Mailho-Fontana PL, Marques-Porto R, Sciani JM, Pimenta DC, Brodie Jr. ED, Antoniazzi MM. Skin gland concentrations adapted to different evolutionary pressures in the head and posterior regions of the caecilian siphonops annulatus. Sci Rep. 2018;1:3576. 9. Toledo RC, Jared C. Cutaneous granular glands and amphibian venom. Comp Biochem Physiol. 1995;1-29. 10. Zhang Y, Yuan B, Takagi N, Wang H, Zhou Y, Si N, Yang J, Wei X, Zhao H, Bian B. Comparative analysis of hydrophilic ingredients in toad skin and toad venom using the UHPLC-HR-MS/MS and UPLC-QqQ- MS/MS methods together with the anti-inflammatory evaluation of indolealkylamines. Molecules. 2018;24:86. 11. Ramana KV, Singhal SS, Reddy AB. Therapeutic potential of natural pharmacological agents in the treatment of human diseases. BioMed Res Int. 2014;573452. 12. Meng Q, Yau LF, Lu JG, Wu ZZ, Zhang BX, Wang JR, Jiang ZH. Chemical profiling and cytotoxicity assay of bufadienolides in toad venom and toad skin. J Ethnopharmacol. 2016;187:74-82. 13. Sharom FJ. The P-glycoprotein efflux pump: how does it transport drugs? J Membr Biol. 1997;160:161-175. 14. Lin JH, Yamazaki M. Role of P-glycoprotein in pharmacokinetics: clinical implications. Clin Pharmacokinet. 2003;42:59-98. 15. Hoosain FG, Choonara YE, Tomar LK, Kumar P, Tyagi C, du Toit LC, Pillay V. Bypassing P-glycoprotein drug efflux mechanisms: possible applications in pharmacoresistant schizophrenia therapy. Biomed Res Int. 2015;2015:484963. 16. Amin ML. P-glycoprotein inhibition for optimal drug delivery. Drug Target Insights. 2013;7:27-34. 17. Kon